Employer record no. 17051
Mersana Therapeutics, Inc.
US DOL LCA disclosure data, FY2021 to FY2026
Total LCA filings
19
Certified
13
Denied
0
FY2024 filings
5
Filings by fiscal year
* partial fiscal year; quarters still being published by DOL
Peer rank
#1,501 of 2,686 healthcare employers by filings
The ledger
| Fiscal year | Filed | Certified | Denied | Avg offered wage | Avg prevailing |
|---|---|---|---|---|---|
| FY2021 | 7 | 7 | 0 | $105,721 | $91,565 |
| FY2022 | 4 | 1 | 0 | $154,262 | $99,721 |
| FY2023 | 1 | 1 | 0 | $110,000 | $96,242 |
| FY2024 | 5 | 4 | 0 | $143,528 | $106,350 |
| FY2026 * | 2 | 0 | 0 | $155,683 | $109,096 |
What they file for
- senior associate scientist, biology/immuno-oncology$104,0005
- accounting manager$132,0472
- associate director- new product strategy$194,6052
- clinical statistical programmer$117,0002
- principal associate scientist, analytical chemistry$116,7602
- senior associate scientist$87,0002
- senior manager, pharmacovigilance scientist$175,0002
- associate director, statistical programming$210,0001
Where
- cambridge, ma19
Every number on this page is free. Members get an email when this employer files again, a CSV of the full record, and the complete rankings with state and job-title filters.
Watch this employerGet the quarterly H-1B update, free
When DOL publishes new filings we send what changed: the biggest movers and the slimmest wage premiums. No account needed. Members also get alerts for Mersana Therapeutics, Inc. and any other employer they watch.
Certification rate 68.4%How these numbers are computed